- 2009.06.17
- Takara Bio Inc. to supply RetroNectin® to U.S. and Europe for multicentre clinical trials of gene therapy targeting X-linked Severe Combined Immunodeficiency (X-SCID)
- 2009.06.04
- Takara Bio and Kohjin-bio form an alliance in the field of cell culture media
- 2009.05.12
- Announcement of Takara Bio's mid-term management plan
- 2009.04.22
- National Cancer Center in Japan gains a regulatory approval of the clinical research for HSV-TK "haplo add-back" gene therapy in treatment of leukemia
- 2008.12.01
- Supply of RetroNectin® to UCLA for TCR-gene therapy clinical trials of advanced melanoma
Copyright © 2010 TAKARA BIO INC. All rights reserved.